Literature DB >> 7076018

Clostridium difficile toxin in acute diarrhoea complicating inflammatory bowel disease.

M R Keighley, D Youngs, M Johnson, R N Allan, D W Burdon.   

Abstract

The incidence of Clostridium difficile cytotoxin has been studied in 69 consecutive patients with inflammatory bowel disease complicated by severe diarrhoea or ileostomy flux during 74 admissions to hospital. The cytotoxin was identified in only four patients, all of whom had received antimicrobials. Clostridium difficle, but not cytotoxin, was identified in 10 of 43 admissions. This followed antimicrobial prophylaxis to cover a recent operation in two patients, and five were on long-term sulphasalazine. Only three patients with Clostridium difficile had not received an antimicrobial within one month of the study. Isolation of Clostridium difficile alone is of doubtful pathological significance, as it spontaneously disappeared without treatment in all patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7076018      PMCID: PMC1419689          DOI: 10.1136/gut.23.5.410

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  16 in total

Review 1.  Antimicrobial agent-induced diarrhea--a bacterial disease.

Authors:  W L George; V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

2.  Pseudomembranous colitis.

Authors:  A B Price; D R Davies
Journal:  J Clin Pathol       Date:  1977-01       Impact factor: 3.411

3.  Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery.

Authors:  M R Keighley; Y Arabi; J Alexander-Williams; D Youngs; D W Burdon
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

4.  Clostridial toxin in faeces of healthy infants.

Authors:  P J Rietra; K W Slaterus; H C Zanen; S G Meuwissen
Journal:  Lancet       Date:  1978-08-05       Impact factor: 79.321

5.  Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia.

Authors:  J G Bartlett; T W Chang; M Gurwith; S L Gorbach; A B Onderdonk
Journal:  N Engl J Med       Date:  1978-03-09       Impact factor: 91.245

6.  Influence of bowel preparation and antimicrobials on colonic microflora.

Authors:  Y Arabi; F Dimock; D W Burdon; J Alexander-Williams; M R Keighley
Journal:  Br J Surg       Date:  1978-08       Impact factor: 6.939

7.  Clindamycin-induced enterocolitis in hamsters.

Authors:  R H Lusk; R Fekety; J Silva; R A Browne; D H Ringler; G D Abrams
Journal:  J Infect Dis       Date:  1978-04       Impact factor: 5.226

8.  Randomised controlled trial of vancomycin for pseudomembranous colitis and postoperative diarrhoea.

Authors:  M R Keighley; D W Burdon; Y Arabi; J A Williams; H Thompson; D Youngs; M Johnson; S Bentley; R H George; G A Mogg
Journal:  Br Med J       Date:  1978-12-16

9.  Diarrhoea and pseudomembranous colitis after gastrointestinal operations. A prospective study.

Authors:  M R Keighley; D W Burdon; J Alexander-Williams; N Shinagawa; Y Arabi; H Thompson; D Youngs; S Bentley; R H George
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

10.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

View more
  9 in total

Review 1.  Crohn's disease and infections: a complex relationship.

Authors:  Gert De Hertogh; Karel Geboes
Journal:  MedGenMed       Date:  2004-08-10

Review 2.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship.

Authors:  Udayakumar Navaneethan; Preethi Gk Venkatesh; Bo Shen
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

4.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

5.  Recent developments on the role of Clostridium difficile in inflammatory bowel disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

6.  Clostridium difficile and inflammatory bowel disease.

Authors:  C Greenfield; J R Aguilar Ramirez; R E Pounder; T Williams; M Danvers; S R Marper; P Noone
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

Review 7.  Laboratory diagnosis of Clostridium difficile-associated diarrhoea.

Authors:  R A Bowman; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

8.  Clostridium difficile, sulphasalazine, and ulcerative colitis.

Authors:  D A Burke; A T Axon
Journal:  Postgrad Med J       Date:  1987-11       Impact factor: 2.401

9.  MICROBIOTA INSIGHTS IN CLOSTRIDIUM DIFFICILE INFECTION AND INFLAMMATORY BOWEL DISEASE.

Authors:  C Rodríguez; E Romero; L Garrido-Sanchez; G Alcaín-Martínez; R J Andrade; B Taminiau; G Daube; E García-Fuentes
Journal:  Gut Microbes       Date:  2020-03-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.